RA treatment could help reduce risk of type 2 diabetes

04/11/2011 | Modern Medicine

Patients with rheumatoid arthritis who use tumor necrosis factor alpha may have a reduced risk of developing insulin resistance, a study in Arthritis Care & Research found. Researchers said that TNF alpha antagonists helped control RA-related inflammation and may improve insulin sensitivity when used over time, which could reduce the risk of type 2 diabetes and cardiovascular disease for these patients.

View Full Article in:

Modern Medicine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC